IFG
GILD icon

Independent Financial Group’s Gilead Sciences GILD Stock Holding History

Independent Financial Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.42M Buy
11,214
+425
+4% +$56K 0.03% 570
2026
Q1 		$1.5M Buy
10,789
+81
+0.8% +$11.3K 0.03% 490
2025
Q4 		$1.31M Sell
10,708
-423
-4% -$51.4K 0.03% 529
2025
Q3 		$1.24M Sell
11,131
-6,134
-36% -$697K 0.03% 543
2025
Q2 		$1.91M Buy
17,265
+4,661
+37% +$496K 0.05% 352
2025
Q1 		$1.41M Buy
12,604
+1,879
+18% +$194K 0.05% 382
2024
Q4 		$991K Sell
10,725
-3,130
-23% -$282K 0.03% 478
2024
Q3 		$1.16M Buy
13,855
+3,070
+28% +$234K 0.04% 404
2024
Q2 		$740K Buy
10,785
+628
+6% +$41.9K 0.03% 480
2024
Q1 		$744K Sell
10,157
-5,276
-34% -$406K 0.03% 465
2023
Q4 		$1.25M Sell
15,433
-3,708
-19% -$289K 0.07% 303
2023
Q3 		$1.43M Buy
19,141
+9,345
+95% +$719K 0.09% 241
2023
Q2 		$755K Sell
9,796
-890
-8% -$71K 0.05% 379
2023
Q1 		$887K Sell
10,686
-2,399
-18% -$199K 0.07% 304
2022
Q4 		$1.12M Sell
13,085
-394
-3% -$31.2K 0.1% 211
2022
Q3 		$832K Sell
13,479
-7,141
-35% -$450K 0.08% 263
2022
Q2 		$1.27M Buy
20,620
+6,850
+50% +$424K 0.14% 171
2022
Q1 		$819K Buy
13,770
+219
+2% +$14K 0.07% 304
2021
Q4 		$984K Sell
13,551
-634
-4% -$43.7K 0.08% 255
2021
Q3 		$991K Buy
14,185
+671
+5% +$47.1K 0.1% 218
2021
Q2 		$931K Buy
13,514
+3,433
+34% +$229K 0.1% 232
2021
Q1 		$652K Buy
10,081
+4,401
+77% +$284K 0.08% 259
2020
Q4 		$331K Sell
5,680
-1,241
-18% -$74.9K 0.05% 401
2020
Q3 		$437K Sell
6,921
-206
-3% -$14.3K 0.08% 271
2020
Q2 		$548K Sell
7,127
-2,352
-25% -$180K 0.12% 207
2020
Q1 		$709K Buy
+9,479
New +$655K 0.21% 126

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Independent Financial Group's GILD Position: Q2 2026 in Review

Independent Financial Group increased its Gilead Sciences (GILD) stake by 3.9% in Q2 2026, buying an estimated $56K and bringing the position to 11,214 shares worth $1.42M. The position accounts for 0.03% of the portfolio, ranked #570.

Independent Financial Group first reported a position in GILD in Q1 2020 and has held it in 26 quarters since. The position peaked at $1.91M in Q2 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Independent Financial Group held 11,214 shares of Gilead Sciences worth $1.42M as of Q2 2026.
  • Independent Financial Group bought 425 Gilead Sciences shares in Q2 2026, an estimated $56K.
  • Gilead Sciences made up 0.03% of Independent Financial Group's portfolio in Q2 2026, its #570 holding.
  • Independent Financial Group first reported a position in Gilead Sciences in Q1 2020 and has held it in 26 quarters since.
  • Independent Financial Group's Gilead Sciences position peaked at $1.91M in Q2 2025.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Independent Financial Group's 13F filing for Q2 2026, filed 15 Jul 2026.